BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 32497711)

  • 21. Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis.
    Alkon N; Assen FP; Arnoldner T; Bauer WM; Medjimorec MA; Shaw LE; Rindler K; Holzer G; Weber P; Weninger W; Freystätter C; Chennareddy S; Kinaciyan T; Farlik M; Jonak C; Griss J; Bangert C; Brunner PM
    J Allergy Clin Immunol; 2023 Aug; 152(2):420-435. PubMed ID: 37210042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic Nodular Prurigo: An Update on the Pathogenesis and Treatment.
    Wong LS; Yen YT
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current novel approaches in systemic therapy of atopic dermatitis: specific inhibition of cutaneous Th2 polarized inflammation and itch.
    Werfel T; Biedermann T
    Curr Opin Allergy Clin Immunol; 2015 Oct; 15(5):446-52. PubMed ID: 26308331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic pruritus--pathogenesis, clinical aspects and treatment.
    Metz M; Ständer S
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1249-60. PubMed ID: 20846147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical aspects and management of chronic itch.
    Zeidler C; Raap U; Witte F; Ständer S
    J Allergy Clin Immunol; 2023 Jul; 152(1):1-10. PubMed ID: 37178730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current pharmaceutical developments in atopic dermatitis.
    Misery L; Huet F; Gouin O; Ständer S; Deleuran M
    Curr Opin Pharmacol; 2019 Jun; 46():7-13. PubMed ID: 30611103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers for itch and disease severity in atopic dermatitis.
    Lee CH; Yu HS
    Curr Probl Dermatol; 2011; 41():136-148. PubMed ID: 21576954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathic Pain and Itch Mechanisms Underlying Allergic Conjunctivitis.
    Kuruvilla M; Kalangara J; Lee FEE
    J Investig Allergol Clin Immunol; 2019; 29(5):349-356. PubMed ID: 30222114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic pruritus associated with dermatologic disease in infancy and childhood: update from an interdisciplinary group of dermatologists and pediatricians.
    Metz M; Wahn U; Gieler U; Stock P; Schmitt J; Blume-Peytavi U
    Pediatr Allergy Immunol; 2013 Sep; 24(6):527-39. PubMed ID: 23980845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Understanding of Pathophysiological Mechanisms of Atopic Dermatitis: Interactions among Skin Barrier Dysfunction, Immune Abnormalities and Pruritus.
    Fujii M
    Biol Pharm Bull; 2020; 43(1):12-19. PubMed ID: 31902917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-31: a new link between T cells and pruritus in atopic skin inflammation.
    Sonkoly E; Muller A; Lauerma AI; Pivarcsi A; Soto H; Kemeny L; Alenius H; Dieu-Nosjean MC; Meller S; Rieker J; Steinhoff M; Hoffmann TK; Ruzicka T; Zlotnik A; Homey B
    J Allergy Clin Immunol; 2006 Feb; 117(2):411-7. PubMed ID: 16461142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-31 pathway and its role in atopic dermatitis: a systematic review.
    Saleem MD; Oussedik E; D'Amber V; Feldman SR
    J Dermatolog Treat; 2017 Nov; 28(7):591-599. PubMed ID: 28145790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-31 as a Clinical Target for Pruritus Treatment.
    Kabashima K; Irie H
    Front Med (Lausanne); 2021; 8():638325. PubMed ID: 33644103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Itch in Atopic Dermatitis Management.
    Kamata Y; Tominaga M; Takamori K
    Curr Probl Dermatol; 2016; 50():86-93. PubMed ID: 27578076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Itch Management: Treatments under Development.
    Pereira MP; Ständer S
    Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Itch Management: Physical Approaches (UV Phototherapy, Acupuncture).
    Chan IH; Murrell DF
    Curr Probl Dermatol; 2016; 50():54-63. PubMed ID: 27578072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Itch in Atopic Dermatitis.
    Pavlis J; Yosipovitch G
    Am J Clin Dermatol; 2018 Jun; 19(3):319-332. PubMed ID: 29285724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs on the Horizon for Chronic Pruritus.
    McEwen MW; Fite EM; Yosipovitch G; Patel T
    Dermatol Clin; 2018 Jul; 36(3):335-344. PubMed ID: 29929605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholestatic pruritus: Emerging mechanisms and therapeutics.
    Patel SP; Vasavda C; Ho B; Meixiong J; Dong X; Kwatra SG
    J Am Acad Dermatol; 2019 Dec; 81(6):1371-1378. PubMed ID: 31009666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: mechanisms and management of itch in atopic dermatitis.
    Ikoma A
    J Pharmacol Sci; 2009 Jul; 110(3):265-9. PubMed ID: 19609064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.